Legal & General Group
ATYR icon

Legal & General Group’s aTyr Pharma ATYR Stock Holding History

Legal & General Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,920
Closed -$6.18K – 3556
2026
Q1 		$6.18K Sell
7,920
-1,650
-17% -$1.39K ﹤0.01% 3261
2025
Q4 		$7.49K Hold
9,570
– – ﹤0.01% 3302
2025
Q3 		$6.9K Hold
9,570
– – ﹤0.01% 3341
2025
Q2 		$48.5K Buy
+9,570
New +$37.7K ﹤0.01% 2712

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legal & General Group's ATYR Position: Q2 2026 in Review

Legal & General Group sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 7,920 shares — an estimated $6.18K sold.

Legal & General Group first reported a position in ATYR in Q2 2025 and held it in 4 quarters. The position peaked at $48.5K in Q2 2025. 89 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Legal & General Group reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 7,920 aTyr Pharma shares in Q2 2026, an estimated $6.18K.
  • Legal & General Group first reported a position in aTyr Pharma in Q2 2025 and held it in 4 quarters.
  • Legal & General Group's aTyr Pharma position peaked at $48.5K in Q2 2025.
  • 89 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.